What do Vaccines and Commercial Real Estate Have In Common?
May 18, 2020
At PLUM, we applaud Moderna and Sorrento for their breakthrough accomplishments and recognize the value in the combination of data science and technology. We apply similar principles in delivering a capital product to our borrowers.
These significant developments in the treatment/prevention of COVID-19 are a result of the combination of technology and science with unprecedented virtual teamwork around the globe. They provide hope and a glimpse into the potential for returning to a normal work, school, and recreational environment.
During the time it takes to complete trials and production, the economy will continue to face significant challenges due to limitations in our movements and interactions. Our goal at PLUM is to consistently provide reasonably priced solutions for our middle market clients with commercial real estate loans ranging from $3-50MM.
- Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
For information on how your immediate financing needs may be met, contact a PLUM expert.
PLUM Lending is a full-service commercial real estate lender that provides creative structured finance solutions for a full range of property types. We specialize in the capitalization of middle-market commercial real estate properties nationwide with a focus on secondary markets. We provide borrowers with capital through our PLUM SELECT direct lending program, as well as our capital markets financing program.
Resolute Capital Partners, announced March 31, 2020 the company has joined Elliott Management, a hedge fund manager, and Soft Bank, a high-tech funding firm, by investing alongside them in PLUM® Lending.Read More >>
Larger investment in the student housing sector reached a new peak in 2018 and continued its strength, with only a brief slowdown when interest rates rose at the beginning of 2019. Learn more about trends in Student Housing as we look into 2020.Read More >>